Sunday 11 October 2026 Export all LLY data to Excel Powerpack

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,179.27 9.67 +0.83%
Market cap
$1.10T
P/E
39.6×
Fwd P/E
33.1×
Dividend yield
0.57%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

8 7 8 9
ROE
96.47% 101.16% 107.46% 102.29%
ROA
19.33% 21.59% 24.54% 21.97%
ROIC
25.82% 26.61% 30.18% 26.33%
Return on Tangible Assets
41.61% 45.79% 56.50% 57.79%
Average Days of Receivables
119.52 112.87 106.99 107.56
Free Cash Flow per Share
10.34 10.00 13.22 20.38
Free Cash Flow
9,271.80 8,972.00 11,823.00 18,190.00
Capital Expenditures
(6,790.50) (7,841.00) (8,657.00) (9,893.00)
Other line items
Cash ROIC
12.42% 11.76% 15.59% 18.61%
Accounts Receivable Turnover
3.77 3.90 4.11 3.92
Accounts Payable Turnover
2.82 2.57 2.93 2.60
Inventory Turnover
1.03 1.04 1.04 0.95
Average Days of Payables
154.26 177.65 147.98 168.70
Days of Inventory on Hand
440.85 453.91 427.53 463.51
Tax Rate
(0.18) (0.20) (0.19) (0.20)
Research and Development Expense of Revenue
21.13% 20.46% 19.53% 18.32%
Selling, General and Administrative Expense of Revenue
17.48% 17.02% 16.00% 15.36%
Share Based Compensation of Revenue
1.06% 0.96% 0.88% 0.81%
Interest Coverage
— — — 83.46
Operating CF/Net income
0.87 0.81 0.81 1.05
Depreciation/Fixed assets
0.09 0.08 0.08 0.07
Capex/Depreciation
(3.58) (3.93) (4.24) (4.71)
Revenue per Share
66.25 72.64 80.77 89.27
Operating CF per Share
17.91 18.74 22.90 31.47
Capex per Share
(7.57) (8.74) (9.68) (11.09)
Capex to Sales
0.11 0.12 0.12 0.12

Fold the line items

Columns are period end dates